GLP-1 receptor agonists may significantly reduce the risk for cardiovascular events in patients with rheumatoid arthritis ...

A population-based cross-sectional study published in Clinical Rheumatology reveals that individuals with rheumatoid ...

Now, with up to 9 years of follow-up, Koray Tascilar, MD, of Friedrich-Alexander-Universität in Erlangen, Germany, said that ...

Tocilizumab alone and in combination with methotrexate outperformed the latter drug in patients who did not adequately ...

Among patients with mNSCLC receiving ICIs, overall survival was similar between those with vs without coexisting RA.

Sustained remission at 10 years was more common as well among the patients starting anti-TNFs right away, Toyoda told ...

Rheumatoid arthritis is a painful and disabling autoimmune disease that affects more than 1% of people worldwide. In the ...

The COVID-19 pandemic caused by SARS-CoV-2 infection is marked by excessive inflammation of several organs, leading to ...

Dr Adedolapo Fasawe, mandate secretary for health and environment and Dr Abubakar Kana, permanent secretary at the Federal ...

A recent study discovered an exponential rise in rheumatoid arthritis all across the globe.Researchers found that the ...

Sleep disturbances have been identified to significantly compromise pain interference in early rheumatoid arthritis (RA) ...